123 Main Street, New York, NY 10001

Contact us

Advanced Therapies

Cutting-edge treatment options designed to target cancer at the cellular level, complementing traditional approaches with innovative methodologies.

Start explore

Q-RESTRAIN™

A proprietary targeted therapy designed to inhibit cancer cell proliferation while preserving healthy cells.

Q-REstrain™ is a personalized treatment that uses RNA interference (RNAi) technology to target specific genes in your body. By analyzing a blood sample, the lab identifies genes related to cancer cells, Lyme disease, and various viruses. The lab then isolates molecules called microRNAs from the patient’s sample, which help silence the identified genes.

After detecting the targeted genes, the lab ensures they are accurately chosen by testing them using computer models and lab experiments. This process guarantees that Q-REstrain specifically targets only the relevant genes without affecting others. Once the best gene targets are confirmed, the lab uses small RNA molecules that match the specific gene sequence, which helps block the gene’s ability to produce proteins essential for cell function and survival. The ultimate goal is to stop the growth of harmful cells by preventing the production of proteins they need to survive.

Clavic-Q-RE™

An advanced immunomodulatory therapy that enhances the body’s natural defenses against cancer cells.

Clavic-Q-RE™ is an advanced immunomodulatory therapy that enhances the body’s natural defense mechanisms against cancer. It stimulates the production and activity of cytotoxic T-cells and natural killer (NK) cells, which play a critical role in identifying and destroying abnormal cells. This therapy is particularly beneficial for patients with compromised immune systems due to chemotherapy or the disease itself. Administered as a series of injections, Clavic-Q-RE™ helps restore immune balance and may reduce the risk of recurrence in remission phases.

Vaccine Prep (ATA)

Advanced preparation therapy to optimize the immune system’s response to cancer vaccines.

Vaccine Prep (ATA) refers to Advanced Tumor Antigen preparation therapy, a pre-immunization protocol designed to optimize the body’s response to cancer vaccines. This therapy involves priming the immune system with targeted antigens derived from the patient’s own tumor cells, ensuring that subsequent vaccine administration triggers a stronger, more specific immune reaction. ATA is often used before dendritic cell vaccines or peptide-based vaccines to enhance their efficacy, particularly in patients with low immunogenicity (weak natural immune response to cancer cells).

Dendritic Cell Therapy

Personalized immunotherapy that activates dendritic cells to recognize and attack cancer cells.

Dendritic Cell Therapy is a form of personalized immunotherapy that harnesses the body’s dendritic cells—key “messengers” of the immune system—to recognize and attack cancer cells. The process involves extracting dendritic cells from the patient’s blood, exposing them to tumor antigens in a lab to “train” them to identify cancer, and reintroducing them into the body. Once reintroduced, these activated cells instruct other immune cells (like T-cells) to target and destroy malignant cells. This therapy is used across various cancer types, including melanoma, prostate, and colorectal cancer, and is often combined with other treatments to boost long-term immune surveillance.

Mistletoe Therapy

Biological therapy using standardized mistletoe extracts to stimulate immune response and inhibit tumor growth.

Mistletoe Therapy uses standardized extracts from the Viscum album plant, which contain bioactive compounds that stimulate immune function and may directly inhibit tumor growth. The extracts are administered via subcutaneous injections, typically near the tumor site or lymph nodes. Mistletoe therapy is recognized for its dual benefits: enhancing immune cell activity (e.g., increasing NK cell counts) and reducing treatment-related side effects like fatigue, nausea, and pain. It is commonly used in integrative oncology to improve quality of life and support conventional treatments, particularly in Europe and integrative clinics worldwide.

Ozone + IV Therapies

Combined ozone therapy with intravenous nutrient protocols to enhance cellular oxygenation and detoxification.

This combined therapy pairs ozone therapy with intravenous nutrient protocols to enhance cellular oxygenation and detoxification. Ozone (O₃) is administered via autohemotherapy (mixing a small amount of the patient’s blood with ozone and reinfusing it) to increase oxygen delivery to tissues and stimulate antioxidant pathways. Concurrently, IV nutrients—such as high-dose vitamin C, glutathione, and B-complex vitamins—support cellular repair and reduce oxidative stress. This combination is used to improve energy levels, enhance detoxification, and potentially increase the sensitivity of cancer cells to other treatments.

Hyperthermia

Targeted heat therapy to damage and destroy cancer cells while improving the effectiveness of other treatments.

Hyperthermia is a non-invasive therapy that uses controlled heat (typically 40–43°C / 104–109.4°F) to damage and destroy cancer cells. Heat is delivered locally (to a specific tumor), regionally (to a body cavity or limb), or systemically, depending on the cancer’s location and stage. Cancer cells are more sensitive to heat than healthy cells, making hyperthermia effective at killing them directly and improving the uptake of chemotherapy drugs or radiation in targeted areas. It is often used for recurrent or resistant tumors, including breast, cervical, and bladder cancer.

Precision Supplementation (via RGCC Data)

Customized nutrient protocols based on RGCC genetic analysis to support treatment response and minimize side effects.

Precision Supplementation involves customized nutrient protocols based on RGCC (Research Genetic Cancer Center) testing, which analyzes a patient’s tumor cells for genetic mutations, drug resistance markers, and metabolic vulnerabilities. Using this data, clinicians recommend specific supplements (e.g., curcumin, resveratrol, or omega-3 fatty acids) to target identified weaknesses in the cancer’s biology. This approach ensures supplements work synergistically with other treatments, potentially enhancing efficacy while reducing side effects.

Finding the Right Therapy for You

Each patient's journey is unique. Our team of specialists will evaluate your specific condition and recommend the most appropriate combination of therapies for your individual needs.

Expert Consultation

Personalized assessment with our medical team

Diagnostic Testing

Comprehensive analysis to guide therapy selection

Treatment Plan

Customized therapy recommendations

Monitoring

Regular evaluation of therapy effectiveness

Ready to Explore Advanced Therapy Options?

Our specialists are here to answer your questions and help you understand which therapies may be right for you.

Schedule a Consultation